Sponsor
Gan & Lee Pharmaceuticals.
Clinical research sponsor
How to interpret these research links
Connected source recordsThe exact organization name Gan & Lee Pharmaceuticals. appears in 23 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
23 shownA Phase 1 Study of GZC8072 Tablets Following a Single Dose in Healthy Study Participants and Multiple Doses in Obese/Overweight Study ParticipantsNCT07784699 · lead sponsor · 2026-09-02
RECRUITINGEvaluate the Efficacy and Safety of GZR33 Injection in Patients With Type 2 DiabetesNCT07527078 · lead sponsor · 2026-04-07
RECRUITINGExtension Study of the Phase 3 Clinical Study of GZR18 Injection for Weight LossNCT07292441 · lead sponsor · 2026-01-22
RECRUITINGBioequivalence Study of GZR18 Injection Before and After CMC ChangeNCT07355738 · lead sponsor · 2026-01-09
RECRUITINGStudy on Gastric Emptying Effect and Drug-Drug Interactions of GZR18 InjectionNCT07128888 · lead sponsor · 2025-11-17
RECRUITINGA Phase IIIb Clinical Study to Assess the Efficacy and Safety of GZR4 in Subjects With Type 2 Diabetes Mellitus Treated With Basal InsulinNCT07165223 · lead sponsor · 2025-10-17
RECRUITINGPhase III Clinical Study Comparing the Efficacy and Safety of GZR18 Injection and Semaglutide (Wegovy®) in Adult Obese or Overweight SubjectsNCT07150975 · lead sponsor · 2025-09-23
RECRUITINGStudy of Pharmacokinetics and Safety of GZR18 Injection in Subjects With Liver Insufficiency and Normal Liver FunctionNCT07144098 · lead sponsor · 2025-08-12
RECRUITINGStudy of Pharmacokinetics and Safety of GZR18 Injection in Subjects With Renal Impairment and Normal Renal FunctionNCT07141030 · lead sponsor · 2025-04-11
RECRUITINGA Phase I Clinical Study of GLR2037 in Patients With Advanced Prostate CancerNCT07468396 · lead sponsor · 2026-04-30
NOT_YET_RECRUITINGEvaluate the Efficacy and Safety of GZR18 Injection in Obese Subjects With Obstructive Sleep Apnea Not Treated With Positive Airway Pressure (PAP) TherapyNCT07493057 · lead sponsor · 2026-04-27
NOT_YET_RECRUITINGEvaluate the Efficacy and Safety of GZR101-80 Injection in Patients With Type 2 DiabetesNCT07387003 · lead sponsor · 2026-04-10
NOT_YET_RECRUITINGEvaluate the Efficacy and Safety of GZR18 Injection in Obese Subjects With Obstructive Sleep Apnea Receiving Positive Airway Pressure (PAP) TherapyNCT07501832 · lead sponsor · 2026-03-27
NOT_YET_RECRUITINGPharmacokinetic and Safety Study of GZR4 Injection in Subjects With Hepatic ImpairmentNCT07193147 · lead sponsor · 2025-10-20
ACTIVE_NOT_RECRUITINGA Study to Compare the Efficacy and Safety of GZR102 Injection and GZR18 Injection in Type 2 Diabetes MellitusNCT07055386 · lead sponsor · 2025-08-07
ACTIVE_NOT_RECRUITINGA Phase I Study to Evaluate the PK and PD Profiles of GZR102 Injection Versus GZR4 Injection and GZR18 Injection Given Separately in Chinese Adult Overweight SubjectsNCT06974487 · lead sponsor · 2025-05-08
NOT_YET_RECRUITINGThe Study of [14C] GZR18NCT07119450 · lead sponsor · 2025-05-07
COMPLETEDA Phase III Clinical Study to Assess the Efficacy and Safety of GZR4 in Type 2 Diabetes Mellitus Subjects (T2DM) Treated With Basal + Prandial InsulinNCT06767761 · lead sponsor · 2025-02-18
ACTIVE_NOT_RECRUITINGA Phase III Clinical Study to Assess the Efficacy and Safety of GZR4 in Insulin-naive Subjects With Type 2 Diabetes Mellitus (T2DM)NCT06767735 · lead sponsor · 2025-02-17
ACTIVE_NOT_RECRUITINGA Phase III Clinical Study to Assess the Efficacy and Safety of GZR4 in Subjects With Type 2 Diabetes Mellitus Treated With Basal InsulinNCT06767748 · lead sponsor · 2025-02-15
ACTIVE_NOT_RECRUITINGA Phase III Clinical Study to Evaluate the Efficacy and Safety of GZR18 Injection in Adult Type 2 Diabetes MellitusNCT06778967 · lead sponsor · 2025-02-13
ACTIVE_NOT_RECRUITINGA Phase III Clinical Study to Evaluate the Efficacy and Safety of GZR18 Injection in Subjects With Type 2 Diabetes Mellitus and Poor Blood Glucose Control by Diet and ExerciseNCT06777238 · lead sponsor · 2025-01-16
ACTIVE_NOT_RECRUITINGA Phase III Clinical Study to Evaluate the Efficacy and Safety of GZR18 Injection in Adult Obese/Overweight SubjectsNCT06728124 · lead sponsor · 2024-12-30
ACTIVE_NOT_RECRUITINGDrugs studied in this sponsor's trials
3 mapped RxNorm conceptsThese drug records are connected through ClinicalTrials.gov studies listing Gan & Lee Pharmaceuticals. as a sponsor, collaborator or responsible party. Each count is the number of distinct trials containing the mapped drug intervention. This does not establish that the organization manufactures, owns, sells or developed the drug.
placebo4
insulin degludec1
semaglutide1
Sponsor roles
lead sponsor23
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.